{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:20:43Z","timestamp":1790000443883,"version":"4.0.1"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijbiomac.2026.152334","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:03:36Z","timestamp":1777590216000},"page":"152334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Customization of dextran-based advanced nanotherapeutics in glioblastoma multiforme management: Promises, progress, and prospects"],"prefix":"10.1016","volume":"364","author":[{"given":"Rajshri","family":"Gorad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopan","family":"Nangare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dnyandev","family":"Gadhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivsharan","family":"Dhadde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namdeo","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152334_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1536320","article-title":"Piezo1-related physiological and pathological processes in glioblastoma","volume":"13","author":"Fu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152334_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3747\/co.2007.119","article-title":"Canadian recommendations for the treatment of glioblastoma multiforme","volume":"14","author":"Mason","year":"2007","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0015","series-title":"Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease","first-page":"215","article-title":"Glioblastoma","author":"Maher","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0020","article-title":"Non-coding RNA biosensors for early detection of brain cancer","volume":"566","author":"Ehtiati","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0025","article-title":"Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0030","article-title":"Advancements in nanotechnology-based targeted drug delivery systems for glioblastoma chemotherapy: a comprehensive review","volume":"111","author":"Gupta","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0035","series-title":"Epidemiology and outcome of glioblastoma","first-page":"143","author":"Tamimi","year":"2017"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12247-025-10051-2","article-title":"Design and evaluation of the PLGA nanoparticles containing ketorolac tromethamine in glioblastoma treatment","volume":"20","author":"\u00c7opur","year":"2025","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1200815","article-title":"Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.562798","article-title":"Current opinion on molecular characterization for GBM classification in guiding clinical diagnosis, prognosis, and therapy","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152334_bb0055","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2018.09.038","article-title":"Mutational landscape of secondary glioblastoma guides MET-targeted trial in brain tumor","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ng.3457","article-title":"Integrated genomic characterization of IDH1-mutant glioma malignant progression","volume":"48","author":"Bai","year":"2016","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes","volume":"17","author":"Sipos","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0070","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.apsb.2021.12.019","article-title":"Therapeutic strategies of glioblastoma (GBM): current advances in the molecular targets and bioactive small molecule compounds","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/979748","article-title":"Cytokine patterns in brain tumour progression","volume":"2013","author":"Albulescu","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1670650","article-title":"Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury","volume":"16","author":"Cavalcanti","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152334_bb0085","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/biomedicines13081963","article-title":"Glioblastoma: from pathophysiology to novel therapeutic approaches","volume":"13","author":"Ribeiro","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0090","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0095","article-title":"Lipid nanoparticles for treatment of glioblastoma multiforme: current status of research and clinical translation","volume":"108","author":"Kulkarni","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0100","first-page":"12","article-title":"The epigenetic mechanisms involved in the treatment resistance of glioblastoma","volume":"8","author":"Shahani","year":"2025","journal-title":"Cancer Drug Resist."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/ccij.ccij_82_17","article-title":"Genetics and epigenetics of glioblastoma: therapeutic challenges","volume":"7","author":"Rasras","year":"2018","journal-title":"Clin. Cancer Investig. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2020.12.015","article-title":"Epigenetics of glioblastoma multiforme: from molecular mechanisms to therapeutic approaches","volume":"83","author":"Uddin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semcancer.2009.02.005","article-title":"Epigenetic mechanisms in glioblastoma multiforme","volume":"19","author":"Nagarajan","year":"2009","journal-title":"Semin. Cancer Biol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.152334_bb0125","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.3390\/s23249842","article-title":"Advances in diagnostic tools and therapeutic approaches for gliomas: a comprehensive review","volume":"23","author":"Thenuwara","year":"2023","journal-title":"Sensors"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0130","article-title":"Plant-derived extracellular vesicles as a natural drug delivery platform for glioblastoma therapy: a dual role in preserving endothelial integrity while modulating the tumor microenvironment","volume":"10","author":"Cui","year":"2025","journal-title":"Int. J. Pharm.: X"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152334_bb0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/cells14070494","article-title":"Therapeutic targets in glioblastoma: molecular pathways, emerging strategies, and future directions","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152334_bb0140","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3390\/cancers15072116","article-title":"Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM)","volume":"15","author":"Yalamarty","year":"2023","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.152334_bb0145","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.3390\/ijms23137207","article-title":"Glioblastoma treatment: state-of-the-art and future perspectives","volume":"23","author":"Rodr\u00edguez-Camacho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0155","article-title":"Innovative nanoparticle-based therapeutic strategies against glioblastoma multiforme: a focus on enhanced delivery systems and efficacy","volume":"13","author":"Wang","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152334_bb0160","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.15252\/emmm.201302627","article-title":"Emerging treatment strategies for glioblastoma multiforme","volume":"6","author":"Carlsson","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0165","first-page":"357","article-title":"Treatment options and outcomes for glioblastoma in the elderly patient","volume":"9","author":"Arvold","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152334_bb0170","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0175","doi-asserted-by":"crossref","first-page":"13961","DOI":"10.1038\/srep13961","article-title":"Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species","volume":"5","author":"Mitteer","year":"2015","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.152334_bb0180","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1158\/0008-5472.CAN-19-0680","article-title":"Radiation-induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high-grade gliomas","volume":"79","author":"Todorova","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1039\/D4PM00263F","article-title":"Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches","volume":"2","author":"Dhiman","year":"2025","journal-title":"RSC Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0190","series-title":"Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications","first-page":"293","article-title":"Dextran-based nanomaterials in drug delivery applications","author":"Maity","year":"2021"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152334_bb0195","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152334_bb0200","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.7150\/thno.69682","article-title":"Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy","volume":"12","author":"Upton","year":"2022","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152334_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193300","article-title":"Blood-brain barrier conquest in glioblastoma nanomedicine: strategies, clinical advances, and emerging challenges","volume":"16","author":"Duan","year":"2024","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152334_bb0210","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/pharmaceutics14081697","article-title":"Nanotechnology-based combinatorial anti-glioblastoma therapies: moving from terminal to treatable","volume":"14","author":"Barzegar Behrooz","year":"2022","journal-title":"Pharmaceutics"},{"issue":"35","key":"10.1016\/j.ijbiomac.2026.152334_bb0215","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1039\/D1CC00811K","article-title":"Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications","volume":"57","author":"Wang","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117999","article-title":"Recent advances in dextran-based drug delivery systems: from fabrication strategies to applications","volume":"264","author":"Hu","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152334_bb0225","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1007\/s13346-024-01783-8","article-title":"Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy","volume":"15","author":"Hong","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijbiomac.2016.02.059","article-title":"Use of dextran nanoparticle: a paradigm shift in bacterial exopolysaccharide based biomedical applications","volume":"87","author":"Banerjee","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0235","series-title":"Peptide and Protein Drug Delivery Using Polysaccharides","first-page":"197","article-title":"Protein and peptide delivery through glycogen and dextran","author":"Gomte","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123783","article-title":"Clinical-type dextran: a review on process and enzyme engineering strategies to control molecular weight distribution","volume":"364","author":"Lanvers","year":"2025","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s44347-026-00038-8","article-title":"Multiscale design of chemically crosslinked dextran hydrogels from bulk scaffolds to microgels and nanofibers","volume":"3","author":"Nikpour","year":"2026","journal-title":"Discov. Polym."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105173","article-title":"Dextran-engineered smart nanosystems for intelligent tumor drug targeting","volume":"220","author":"Jain","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.carbpol.2018.02.075","article-title":"Dextran derivatives application as flocculants","volume":"190","author":"Ghimici","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114342","article-title":"Bioactive dextran-based scaffolds from emulsion templates co-stabilized by poly (lactic-co-glycolic acid) nanocarriers","volume":"245","author":"Ducrocq","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152334_bb0265","article-title":"Novel strategies for synthesis and assessment of dextran conjugated 9Z,11E linoleic acid on cancer cell lines viability via Wnt\/\u03b2-catenin signaling pathway and apoptosis","volume":"77","author":"Akan","year":"2025","journal-title":"Starch St\u00e4rke"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152334_bb0270","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1134\/S2635167624601736","article-title":"Study of dextran coated magnetic nanoparticles incorporation into glioblastoma cells","volume":"19","author":"Ryzhov","year":"2024","journal-title":"Nanobiotechnol. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152334_bb0275","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3390\/app15052734","article-title":"Surface-modified ceramic boron carbide as a platform for specific targeting in tumour environments","volume":"15","author":"Kozie\u0144","year":"2025","journal-title":"Appl. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0280","first-page":"344","article-title":"Impact of carboxymethyl dextran-asparaginase in NALM-6 cell apoptosis and autophagy","volume":"25","author":"Azizian","year":"2024","journal-title":"Iran. J. Vet. Res."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0285","article-title":"Engineering and optimizing clomipramine-encapsulated dextran-based polymeric nanoparticles for cancer therapeutics","volume":"110","author":"Shoaib","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0290","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-targeted codelivery of Bcl-2\/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121760","article-title":"Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in cu-loaded glioblastoma resulting in potent growth inhibition","volume":"289","author":"Ismail","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0300","first-page":"1","article-title":"Acetalated dextran (ac-DEX) in targeted drug delivery and cancer immunotherapy: a multipurpose biodegradable polymer","author":"Thakkar","year":"2025","journal-title":"J. Macromol. Sci. B Phys."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40199-025-00561-2","article-title":"Synthesis and optimization of fluoxetine-loaded polymeric nanoparticles for dual therapeutic applications in cancer and depression","volume":"33","author":"Shoaib","year":"2025","journal-title":"DARU J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152334_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202400613","article-title":"Synthesis and characterization of coated CoFe2O4 nanoparticles with biocompatible compounds and in vitro toxicity assessment on glioma cell lines","volume":"12","author":"Ozer","year":"2025","journal-title":"Adv. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114225","article-title":"Biodegradable nanofibrous scaffolds enhance standard of care for glioblastoma via localized targeted therapy","volume":"387","author":"Woodring","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114018","article-title":"Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma","volume":"385","author":"Shumer-Elbaz","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0325","series-title":"Natural Biopolymers for Drug Delivery","first-page":"391","article-title":"Promising potential of dextran-based drug delivery in healthcare management","author":"Kabir","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2020.02.004","article-title":"Hyperthermia and smart drug delivery systems for solid tumor therapy","volume":"163","author":"Seynhaeve","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0340","article-title":"Design and application of dextran carrier","volume":"55","author":"Huang","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152334_bb0345","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1177\/0960327115603588","article-title":"Nanotechnology: history and future","volume":"34","author":"Hulla","year":"2015","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0350","series-title":"Interface Science and Technology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-813586-0.00001-8","article-title":"An introduction to nanotechnology","volume":"28","author":"Nasrollahzadeh","year":"2019"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1441460","article-title":"Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration","volume":"14","author":"Bae","year":"2024","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152334_bb0360","first-page":"3742","article-title":"Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches","volume":"11","author":"Mohiuddin","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0365","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1007\/s12672-025-03807-2","article-title":"Current strategies and novel immunotherapeutic approaches for overcoming immune resistance in glioblastoma","volume":"16","author":"Nourizadeh","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123138","article-title":"Advanced nanoparticle engineering for precision therapeutics of brain diseases","volume":"318","author":"Ismail","year":"2025","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152334_bb0375","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/cells14181458","article-title":"Tumor-associated macrophages in glioblastoma: mechanisms of tumor progression and therapeutic strategies","volume":"14","author":"Chen","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0380","article-title":"Breaking the barrier: nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0385","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics17020142","article-title":"Emerging approaches in glioblastoma treatment: modulating the extracellular matrix through nanotechnology","volume":"17","author":"Horta","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/cancers13020195","article-title":"Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update","volume":"13","author":"Hsu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0395","article-title":"In situ-forming silk fibroin hydrogels containing doxorubicin and ibuprofen-loaded solid lipid nanoparticles with sequential drug release for localized synergistic glioblastoma therapy","volume":"115","author":"Shafaei","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118921","article-title":"Hijacking migration: CXCL12-functionalized hydrogels as a new frontier in glioblastoma therapy","volume":"194","author":"Khorramdelazad","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxnano.2025.100137","article-title":"Nanoparticles assisted drug delivery for effective management of glioblastoma","volume":"7","author":"Damani","year":"2025","journal-title":"Next Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0410","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.matbio.2019.04.003","article-title":"Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma","volume":"85","author":"Xiao","year":"2020","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0415","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.xphs.2024.11.030","article-title":"Targeted thermosensitive liposomes loaded with gold nanoparticles and temozolomide hexadecanoate for the synergistic photothermal-chemotherapy treatment of glioblastoma","volume":"114","author":"Duan","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0420","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0425","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics17010127","article-title":"Nanoparticle-in-hydrogel delivery system for the sequential release of two drugs","volume":"17","author":"van Straten","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0430","article-title":"An injectable in situ hydrogel platform for sustained drug release against glioblastoma","volume":"95","author":"Yue","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152334_bb0435","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/neuroglia6030028","article-title":"Nanomedicine-based advances in brain cancer treatment-a review","volume":"6","author":"Loushambam","year":"2025","journal-title":"Neuroglia"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152334_bb0440","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/ijms26051814","article-title":"Nanotherapy of glioblastoma-where hope grows","volume":"26","author":"Grzegorzewski","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0445","doi-asserted-by":"crossref","DOI":"10.26599\/NR.2026.94908472","article-title":"Nanomedicine-enabled epigenetic therapy for glioblastoma: overcome the blood-brain barrier and therapeutic resistance","volume":"19","author":"Yang","year":"2026","journal-title":"Nano Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152334_bb0450","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood-brain barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202000054","article-title":"Lipid-based nanocarriers for the treatment of glioblastoma","volume":"1","author":"Iturrioz-Rodr\u00edguez","year":"2021","journal-title":"Adv. Nanobiomed Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0460","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/ijms19041155","article-title":"Delivery of proapoptotic agents in glioma cell lines by TSPO ligand-dextran nanogels","volume":"19","author":"Lopalco","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152334_bb0465","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.molpharmaceut.4c01269","article-title":"Protamine-based nanotherapeutics for gene delivery to glioblastoma cells","volume":"22","author":"Barrios-Esteban","year":"2025","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0470","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/ijms24010355","article-title":"Dextran sulfate nanocarriers: design, strategies and biomedical applications","volume":"24","author":"Ramasundaram","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152334_bb0475","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.7150\/thno.123550","article-title":"Engineering polysaccharide nanoplatforms for glioblastoma theranostics: bridging targeted therapy and advanced imaging","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0480","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ijbiomac.2019.11.151","article-title":"Preparation and application of dextran and its derivatives as carriers","volume":"145","author":"Chen","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0485","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2147\/IJN.S152461","article-title":"Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)","volume":"13","author":"Shevtsov","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/medsci14010073","article-title":"Breaking barriers: advancements in CNS drug delivery for glioblastoma","volume":"14","author":"Al Fidawi","year":"2026","journal-title":"Med. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0495","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.colsurfb.2016.01.006","article-title":"Functionalized magnetic nanochains with enhanced MR imaging: a novel nanosystem for targeting and inhibition of early glioma","volume":"140","author":"Zhang","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152334_bb0500","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/pharmaceutics14020279","article-title":"Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma","volume":"14","author":"Ramalho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0505","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152334_bb0510","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1039\/C6BM00846A","article-title":"Redox-responsive dextran-based theranostic nanoparticles for near-infrared\/magnetic resonance imaging and magnetically targeted photodynamic therapy","volume":"5","author":"Ding","year":"2017","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0515","doi-asserted-by":"crossref","first-page":"13540","DOI":"10.1038\/s41598-025-97775-w","article-title":"Dual-enzyme activated theranostic nanoparticles for image-guided glioblastoma therapy","volume":"15","author":"Shokri Varniab","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152334_bb0520","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/acs.biomac.4c00722","article-title":"Stimuli-responsive polymeric nanocarriers accelerate on-demand drug release to combat glioblastoma","volume":"25","author":"Ismail","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0525","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-025-01895-9","article-title":"Intranasal administration of temozolomide-conjugated nanoparticles with transcranial magnetic stimulation improves survival in glioblastoma xenograft models","volume":"16","author":"Koh","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.152334_bb0530","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.3390\/ijms242015150","article-title":"Radiosensitizing effect of dextran-coated iron oxide nanoparticles on malignant glioma cells","volume":"24","author":"Tran","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123276","article-title":"Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer","volume":"643","author":"Khan","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.nwnano.2025.100158","article-title":"Nanoplatform-based theranostics in glioblastoma: a promising frontier for precision oncology","volume":"12","author":"Karthikeyan","year":"2025","journal-title":"Nano Trends"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152334_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103812","article-title":"Anti-microRNA-21 oligonucleotide-loaded spermine-modified acetalated dextran nanoparticles for B1 receptor-targeted gene therapy and antiangiogenesis therapy","volume":"9","author":"Zheng","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0550","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jconrel.2020.04.028","article-title":"Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy","volume":"323","author":"Graham-Gurysh","year":"2020","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152334_bb0555","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acs.molpharmaceut.7b01114","article-title":"Sustained delivery of doxorubicin via acetalated dextran scaffold prevents glioblastoma recurrence after surgical resection","volume":"15","author":"Graham-Gurysh","year":"2018","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152334_bb0560","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1039\/D5BM00259A","article-title":"Supervised machine learning for predicting drug release from acetalated dextran nanofibers","volume":"13","author":"Woodring","year":"2025","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0565","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1038\/s41598-025-87896-7","article-title":"A polysaccharide-based hydrogel platform for tumor spheroid production and anticancer drug screening","volume":"15","author":"Lopez-Vince","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0570","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/IJN.S394377","article-title":"Multifunctional nano-realgar hydrogel for enhanced glioblastoma synergistic chemotherapy and radiotherapy: a new paradigm of an old drug","volume":"18","author":"Wang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152334_bb0575","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/mps8010010","article-title":"Optimized methods to quantify tumor treating fields (TTFields)-induced permeabilization of glioblastoma cell membranes","volume":"8","author":"Martinez-Paniagua","year":"2025","journal-title":"Methods Protoc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152334_bb0580","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/molecules28031086","article-title":"Dextran formulations as effective delivery systems of therapeutic agents","volume":"28","author":"Petrovici","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103045","article-title":"Progress and challenges in the translation of cancer nanomedicines","volume":"85","author":"Tong","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0590","first-page":"1","article-title":"Hydrogen peroxide quantification using zero dimensional carbon nanostructured materials: a review","author":"Sharma","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152334_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178211","article-title":"Berberine sensitizes liver cancer cells to sorafenib by inducing SETDB1\/NQO1\/p53-dependent ferroptosis and genomic instability","volume":"1007","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:55:55Z","timestamp":1789998955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026022610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":119,"alternative-id":["S0141813026022610"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152334","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Customization of dextran-based advanced nanotherapeutics in glioblastoma multiforme management: Promises, progress, and prospects","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152334"}}